Home

Certara, Inc. (CERT)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Certara, Inc. (CERT)

Go deeper and ask any question about CERT

Company Performance

Current Price

as of Sep 13, 2024

$10.95

P/E Ratio

N/A

Market Cap

$1.76B

Description

Certara, Inc. engages in the provision of software and technology-enabled services for drug developers. It offers cell and gene therapy, clinical pharmacology, complex biologics, decision analytics and modeling, drug development and regulatory strategy, and model-based analysis services. The company was founded on June 27, 2017, and is headquartered in Radnor, PA.

Metrics

Overview

  • HQRadnor, PA
  • SectorTechnology Services
  • IndustryPackaged Software
  • TickerCERT
  • Price$10.95+2.15%

Trading Information

  • Market Cap$1.76B
  • Float68.81%
  • Average Daily Volume (1m)1,475,456
  • Average Daily Volume (3m)964,673
  • EPS-$0.49

Company

  • Revenue$363.55M
  • Rev Growth (1yr)3.17%
  • Net Income-$12.57M
  • Gross Margin43.20%
  • EBITDA Margin14.55%
  • EBITDA$13.58M
  • EV$2.31B
  • EV/Revenue6.36
  • P/EN/A
  • P/S4.83
Documents